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Altered Brain Activation in Ventral Frontal–Striatal Regions 
Following a 16-week Pharmacotherapy in Unmedicated 
Obsessive–Compulsive Disorder
Recent studies have reported that cognitive inflexibility associated with impairments in a 
frontal–striatal circuit and parietal region is a core cognitive deficit of obsessive–
compulsive disorder (OCD). However, few studies have examined progressive changes in 
these regions following clinical improvement in obsessive-compulsive symptoms. To 
determine if treatment changes the aberrant activation pattern associated with task 
switching in OCD, we examined the activation patterns in brain areas after treatment. The 
study was conducted on 10 unmedicated OCD patients and 20 matched controls using 
event-related functional magnetic resonance imaging. Treatment improved the clinical 
symptoms measured by the Yale-Brown Obsessive Compulsive Scale and behavioral 
flexibility indicated by the switching cost. At baseline, OCD showed significantly less 
activation in the dorsal and ventral frontal–striatal circuit and parietal regions under the 
task-switch minus task-repeat condition compared with controls. After treatment, the 
neural responses in the ventral frontal–striatal circuit in OCD were partially normalized, 
whereas the activation deficit in dorsal frontoparietal regions that mediate shifting 
attention or behavioral flexibility persisted. It is suggested that altered brain activation in 
ventral frontal-striatal regions in OCD patients is associated with their cognitive flexibility 
and changes in these regions may underlie the pathophysiology of OCD. 
Key Words: Task-Switching; Cognitive Flexibility; Obsessive-Compulsive Disorder; Drug 
Therapy; Ventral Frontal-Striatal Region
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ORIGINAL ARTICLE
Psychiatry & Psychology
INTRODUCTION
Obsessive-compulsive disorder (OCD) is characterized by ste-
reotyped repetitive behaviors and thoughts affecting from a rig-
id conceptual framework (1), in addition to coincident deficits 
in cognitive flexibility during set-shifting (2) or task-switching 
tasks (3). Functional magnetic resonance imaging (fMRI) stud-
ies in OCD have consistently reported an association between 
cognitive inflexibility and aberrant activity in the frontal-striatal 
areas including the orbitofrontal cortex (OFC), dorsolateral pre-
frontal cortex (DLPFC), basal ganglia, and the parietal cortex (4, 
5). Moreover, Chamberlain et al. (4) demonstrated the impor-
tance of these regions, including lateral OFC, lateral PFC, and 
parietal cortex, in the development of OCD pathological behav-
ior and suggested that cognitive inflexibility might represent a 
cognitive OCD endophenotype.
  In agreement with previous studies, we have recently report-
ed a deficit in task-switching ability accompanied by dysfunc-
tional brain activation patterns in patients with OCD compared 
with healthy controls. We suggested an imbalance between the 
dorsal and ventral frontal-striatal regions during the task, includ-
ing the DLPFC, anterior cingulate cortex (ACC), caudate body, 
and OFC, showing hyperresponsive to the repeat condition in 
the ventral frontal-striatal regions and hyporesponsive to the 
switch condition in the dorsal frontal-striatal regions (3). Neu-
roimaging studies indicate that activity in the ventral frontal-stri-
atal regions increases at rest and in response to symptom-pro-
voking stimuli, whereas activity in the dorsal frontal-striatal re-
gions decreases during the performance of executive functions 
such as planning and switching in patients with OCD (3, 6-8). It 
has been suggested that these dysfunctional neuronal respons-
es may be the result of an imbalance between direct (excitatory) 
and indirect (inhibitory) pathways in the frontal-striatal circuit 
and are related to the pathophysiology of OCD (6, 7, 9).Han JY, et al.  •  Brain Activation after Therapy in OCD
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  Several studies have used fMRI to investigate whether dys-
functional activation is normalized following treatment (10-12). 
However, the task paradigms used in previous follow-up stud-
ies (e.g. complex motor task, Stroop task, and working memory 
task) cannot elucidate the changes in neural correlates directly 
related to cognitive inflexibility, particularly task switching, which 
is the core deficit of OCD. Thus, it is unclear whether the brain 
activation pattern associated with cognitive inflexibility observed 
in OCD patients is altered by treatment (i.e., improved clinical 
symptoms and anxiety). A whole-brain imaging analysis is nec-
essary to clarify this issue. 
  Longitudinal PET studies have revealed improved function in 
the ventral frontal-striatal regions in response to treatment with 
selective serotonin reuptake inhibitors (SSRIs) (13-16). In con-
trast, Nielen and Den Boer (17) found that fluoxetine had no clin-
ical effect on cognitive functions mediated by the dorsal frontal-
striatal circuit. Neuropsychological follow-up studies have re-
ported that deficits in executive function mediated by DLPFC 
may not improve completely regardless of the extent of clinical 
improvement (18-20). Taken together, results from previous stud-
ies suggest that treatment may produce differential changes in 
the ventral frontal-striatal regions and the dorsal frontal-striatal 
regions in patients with OCD. Considered the implication in the 
findings of Chamberlain et al. (4), the parietal cortex may show 
dysfunctional activation similar to that of the PFC and basal gan-
glia despite treatment. Thus, in this study we observed changes 
in the parietal cortex in addition to the fronto-striatal regions. 
  The aim of this study is to examine whether pharmacothera-
py could alter the activation pattern in the frontal-striatal circuits 
and parietal region recruited in task-switching. We investigated 
the longitudinal change in the activation pattern related to the 
concurrent deficit of ventral frontal-striatal regions and regula-
tory dysfunctions of the dorsal frontal-striatal and parietal re-
gions in unmedicated OCD patients before and after treatment. 
Based on previous studies and our work, we hypothesized that 
aberrant activation in the ventral frontal-striatal regions that as-
sociated with cognitive inflexibility in OCD would be normal-
ized after treatment, while dysfunctional activation in the dor-
sal frontal-striatal and parietal regions would remain despite 
clinical improvement.
MATERIALS AND METHODS
Subjects
Ten patients diagnosed with OCD according to the criteria of 
the Diagnostic and Statistical Manual of Mental Disorders-IV 
(DSM-IV) were included in the study. An fMRI scan was per-
formed in all patients one week following enrollment in the study 
and after 16 weeks of pharmacological treatment. At baseline, 
nine patients were drug-naive, and one had received medica-
tion for 10 days 1 month prior to inclusion in the study. At fol-
low up, nine patients with OCD were on escitalopram treatment 
(average, 33.1 mg/day; range, 15-50 mg/day) and one patient 
was on fluoxetine (70 mg/day). Anxiolytics and an antipsychot-
ic were added in two patients (2 mg/day of diazepam, 0.5 mg/day 
of clonazepam) and one patient (0.25 mg/day of risperidone), 
respectively. All of the control subjects and four patients were 
overlapped with a previous study (3), and six patients were new-
ly recruited. One patient had comorbid obsessive-compulsive 
personality disorder (OCPD); none of the remaining patients had 
Axis I or major Axis II pathology. The control group consisted of 
20 sex-, age-, handedness-, and IQ (using Korean-Wechsler Adult 
Intelligence Scale-Revised)-matched healthy volunteers. An as-
sessment using the Structured Clinical Interview for DSM-IV 
Non-patient Version (SCID-NP) confirmed that no control sub-
ject had an Axis I psychiatric disorder. Exclusion criteria includ-
Table 1. Demographic characteristics of the patients with OCD and controls
Characteristic Controls (n = 20)  Patients with OCD (n = 10) 
Analysis
χ2/t P
Sex (Male/Female) 18/2                      9/1                 0
† 1
Handedness (Right/Left) 19/1                      9/1 0.27
† 0.60
Age (yr) 24.3 ± 2.9                     23.2 ± 4.5 0.81
‡ 0.42
IQ 114.3 ± 12.9                     112.1 ± 14.8 0.41
‡ 0.69
Education (yr) 14.6 ± 1.0                   13.70 ± 1.6 1.36
‡ 0.65
Illness duration (yr)                       4.4 ± 3.3
Age of onset                     18.5 ± 4.6
Before After
Y-BOCS score
   Obsession
   Compulsion
   Total score
 
-
-
-
 
  10.6 ± 1.9
  10.3 ± 3.1
  20.9 ± 4.5
 
  7.0 ± 3.1
  7.9 ± 4.8
14.9 ± 7.1
 
2.88
§
1.44
§
2.23
§
 
0.02*
0.18
0.05
BDI score   4.5 ± 5.9   12.8 ± 6.2   7.8 ± 8.3 2.20
§ (-3.60
‡)   0.06 (< 0.01*)
BAI score   4.6 ± 4.9   14.6 ± 7.2   7.6 ± 4.9 2.91
§ (-4.53
‡)  0.02* (< 0.01*)
Data are presented as mean ± SD. *P < 0.05; 
†χ2 test comparing OCD patients at baseline versus controls; 
‡Independent t-test comparing OCD patients at baseline versus 
controls; 
§Paired t-test comparing OCD patients at baseline versus OCD patients at follow-up. SD, standard deviation; Y-BOCS, Yale–Brown Obsessive–Compulsive Scale; BDI, 
Beck Depression Inventory; BAI, Beck Anxiety Inventory. Han JY, et al.  •  Brain Activation after Therapy in OCD
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ed a lifetime history of psychosis, substance abuse or depen-
dence, significant head injury, bipolar disorder, Tourette’s dis-
order, seizure disorder, and mental retardation. The demograph-
ic characteristics of the subjects are presented in Table 1. 
  The primary treatment outcome was measured as percent (%) 
improvement between the pre- and post-treatment Yale-Brown 
Obsessive Compulsive Scale (Y-BOCS) score. The Beck Depres-
sion Inventory (BDI) and Beck Anxiety Inventory (BAI) were ad-
ministered at the pre- and post-treatment time points to assess 
changes in depressive and anxiety symptoms as potential con-
founding factors. As seen in most clinical samples of OCD, al-
though subthreshold depressive symptoms were higher in OCD 
patients than healthy controls, no patients were diagnosed with 
major depressive disorder according to the SCID I. 
  We classified the patients according to the five symptom di-
mensions (21) and found the following predominant obsession/ 
compulsions among the patients: contamination/cleaning (n = 
4), aggressive/checking (n = 5) and symmetry/ordering (n = 1). 
Task paradigm 
We used a task-switching paradigm that required the partici-
pants to alter components of their response according to two 
different types of cues (square or diamond) that were previous-
ly demonstrated (3). The stimuli were four kinds of icons: a green 
house, a blue house, a green face, and a blue face. The square or 
diamond cue was presented for 500 ms, followed by a fixation 
cross for 670 ms. The participants were asked to respond to the 
color or shape of the upcoming stimulus, which appeared for 
500 ms. The intertrial interval (ITI) was randomly set between 
1,840 and 5,350 ms. A square cue signaled an upcoming shape 
(face or house) stimulus, and the diamond cue signaled a color 
(blue or green) stimulus. Each trial was classified into the task-
switch or the task-repeat condition, depending on whether the 
upcoming task set was different from or the same as the previ-
ous one. A total of 264 trials were presented, and all participants 
were trained on the stimulus-response set for 10 min prior to 
scanning.
Image acquisition
Whole-brain imaging was performed using a 1.5 Tesla whole 
body scanner (Siemens AVANTO, Erlangen, Germany) with a 
standard head coil. Functional images were obtained using an 
echo-planar imaging sequence (repetition time [TR] = 2,340 ms, 
echo time [TE] = 52 ms, 3.28 × 3.28 × 4 mm
3, flip angle [FA] = 90°), 
yielding 25 axial slices with a 1-mm interslice gap. The fMRI data 
were acquired in four runs of 130 scans of 304 sec each, lasting 
a total of approximately 20 min.
Functional imaging data analysis
The imaging data were analyzed using SPM2 (Wellcome Trust 
Centre for Neuroimaging; http://www.fil.ion.ucl.ac.uk/spm). 
The first three images in each run were discarded to eliminate 
non-equilibrium effects of magnetization. The functional imag-
es were corrected for differences in slice-acquisition timing and 
then realigned to the image in the middle of the second session 
to correct for motion effects. The images were normalized into 
standard stereotactic Montreal Neurological Institute (MNI) 
space using the echo-planar imaging template and resampled 
with a voxel size of 2 × 2 × 2 mm
3. The normalized images were 
smoothed using an 8-mm full-width at half-maximum (FWHM) 
Gaussian kernel. 
  We used a two-phase analysis process in which contrast im-
ages reflecting switching activity in each subject were entered 
into a second-level random effects analysis. Four event types 
(task repeat, task switch, error trials, and post-error trials) were 
defined at the first level of analysis, and the task-switching-re-
lated brain activations were identified from task-switch minus 
the task-repeat contrast images. After confirming the task-switch-
ing-related brain activation using a one-sample t-test analysis 
in each subject group, we performed separate two-sample t-tests 
using the contrast images of task-switch minus task-repeat to 
compare healthy controls and patients with OCD at baseline 
and follow-up. A paired t-test was used to compare the patients 
at baseline and at the 16-week follow-up. Activations were re-
ported using the criteria of P < 0.005 uncorrected at the voxel 
level, with a significance of P < 0.05 at the cluster level for multi-
ple comparisons. For descriptive purpose, we also reported ad-
ditional foci passing uncorrected threshold of P < 0.005 at the 
voxel level when not significant at the cluster level if these were 
consistent with regions of a priori interest based on our previ-
ous study (3) but we do not report any clusters containing fewer 
than 30 voxels to prevent false positives.
  Further analyses using a region of interest (ROI) approach 
were conducted to examine changes in the activation pattern in 
the dorsal circuits, including the dorsal frontal-striatal and pari-
etal regions, and in the ventral circuits, including the ventral 
frontal and limbic/paralimbic regions. Functinoal ROIs were 
identified as regions that showed significant differences between 
the OCD at baseline and control groups and between baseline 
and follow-up in patients with OCD. These functional ROIs in-
cluded the DLPFC, dorsal ACC (peak MNI coordinates: -2, 32, 26), 
caudate, ventrolateral prefrontal cortex (VLPFC), rostral ACC, 
OFC, thalamus, insula, hippocampus, and parietal area. The thal-
amus, insula, and hippocampus were included based on the 
within-patient group comparison, and the other areas were de-
termined from the between-subjects comparison at baseline. 
We estimated the BOLD percentage signal change for each sub-
ject using MarsBaR software (http://marsbar.sourceforge.net/) 
to extract beta values for each condition from a 5-mm sphere 
around the peak-activated voxel for each cluster of the function-
al ROIs in the normalized images, and then calculated the task-
switch activation value compared to the task-repeat activation Han JY, et al.  •  Brain Activation after Therapy in OCD
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value. A one-way analysis of variance (ANOVA) was used to de-
termine the group effect for each ROI, and Fisher’s LSD test was 
used as a post hoc test for group-by-group comparisons. 
Correlation analysis
Correlations between changes in ROI activity (activity at post-
treatment minus activity at pre-treatment) related to flexibility 
(task-switch minus task-repeat condition) and percent improve-
ment on the Y-BOCS, BDI, and BAI scores were examined. Ad-
ditionally, we investigated correlations among the behavioral 
performance changes in switch error rates, switch reaction times 
(RTs), repeat error rates, repeat RTs, and switching cost of RTs 
(task-switch RTs minus task-repeat RTs), improvement of symp-
toms, and longitudinal changes in ROIs. Correlations were as-
sessed using the Pearson product-moment correlation coeffi-
cient. Statistics were performed using SPSS (Version 12.0), and 
statistical significance was set at P = 0.05 (two tailed), corrected 
for multiple testing.
Fixed effects analyses in patients before and after 
treatment separately
Fixed effects analysis does not take appropriate account of the 
between-subjects variance and thus they do not allow popula-
tion inferences. However, it increases detection power and al-
lows for inferences related to the samples. Therefore, we con-
ducted fixed effects analyses to investigate the similarities and 
the differences in task-switching-related brain regions in pa-
tients with OCD before and after treatment. Fixed effects analy-
ses were separately performed in patients at baseline and fol-
low-up by concatenating the data across subjects. These results 
were thresholded at P < 0.005 uncorrected at the voxel level, with 
a significance of P < 0.05 at the cluster level for multiple compar-
isons. 
Ethics statement 
The present study was approved by the institutional review board 
at Seoul National University Hospital (H-1101-066-348). All par-
ticipants provided written informed consent before scanning 
was performed.
RESULTS
Treatment response
After 16 weeks of pharmacotherapy, the patients with OCD 
showed significant clinical improvement compared with the 
pre-treatment assessment (t = 2.23, P = 0.05). Y-BOCS scores 
decreased by 26.1% ± 41.2% (range; -53.3-80.0), and seven pa-
tients showed a greater than 30% reduction in the Y-BOCS score. 
Moreover, the patients showed a significant decrease in anxiety, 
as indicated by a 43.0% ± 36.5% reduction in BAI scores (Table 1).
Behavioral performance
The correct response rate was more than 80% for all subjects 
(control, 95.8% ± 2.4%; OCD baseline, 92.1% ± 8.8%; OCD follow 
up, 94.3% ± 5.4%) except one (baseline, 71.0%). We analyzed er-
ror rates and RTs for the task-switch and task-repeat conditions. 
As previously reported (3), the task-switch error rates were sig-
nificantly higher in the OCD group (at baseline) than in the con-
trol group (P < 0.05). The error rates and RTs tended to be lower 
in the OCD group at follow-up compared with baseline for both 
the task-switch and task-repeat conditions; however, no signifi-
cant differences were observed in these behavioral performanc-
es (Table 2). Switching cost in the OCD group was significantly 
improved following treatment (Table 2). When subjects switch 
from one task to another, the switching cost (the mental effort 
to achieve cognitive flexibility) can be measured by calculating 
task-switch RTs minus task-repeat RTs. An improvement in 
switching cost reduces the energy required for flexibility, and 
cognitive flexibility is improved.
 
Regional patterns of activity after pharmacotherapy
The between-group analysis of the OCD group at baseline and 
controls revealed that the task-switch minus task-repeat condi-
tion produced significantly lower levels of activity in the OCD 
group in the bilateral DLPFC, bilateral parietal area, right rostral 
ACC, left dorsal ACC, bilateral caudate, right OFC, bilateral VLP-
Table 2. Performances of the patients with OCD at baseline, follow-up and the controls during the task-switching paradigm
Condition Error rate (%) Reaction time (s) Switching cost (s)
Controls Task switch
Task repeat
4.41 ± 3.33
4.03 ± 2.93
1.73 ± 0.19
1.70 ± 0.18
0.026 ± 0.040
Patients at baseline Task switch
Task repeat
9.21 ± 9.71
6.46 ± 8.39
1.79 ± 0.21
1.74 ± 0.19
0.051 ± 0.044
Patients at follow-up Task switch
Task repeat
6.98 ± 5.63
4.40 ± 5.27
1.72 ± 0.15
1.70 ± 0.14
0.015 ± 0.020
t (P)* Task switch
Task repeat
0.88 (0.40)
1.71 (0.12)
-1.14 (0.28)
-1.29 (0.23)
3.49 (0.01)
f 2,37 (P) Task switch
Task repeat
 2.21 (0.12)
†
0.72 (0.49)
 0.51 (0.61)
 0.17 (0.89)
 2.52 (0.09)
‡
Data are presented as mean ± SD. *Paired comparison t-tests; 
†LSD post hoc test differs between controls and patients at baseline (P < 0.05); 
‡LSD post hoc test differs 
between patients at baseline and follow-up (P < 0.05).Han JY, et al.  •  Brain Activation after Therapy in OCD
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FC, right insula, and bilateral hippocampus (Table 3, Figs. 1, 2A).
  Repeated-measures analysis revealed that the pharmacother-
apy significantly increased task-switching activity in the right 
rostral ACC, right insula, right posterior cingulate cortex (PCC), 
right parietal area, left thalamus, and left hippocampus (Table 4, 
Fig. 2A). In contrast, treatment decreased activity in the right 
middle temporal gyrus (MTG; MNI coordinates; 52, -34, -10; Z-
value = 3.59) during task switching.
  A comparison of the controls and patients at follow-up using 
the same contrast revealed lower activity in the dorsal frontopa-
rietal regions in the OCD group, including the bilateral DLPFC, 
bilateral dorsomedial prefrontal cortex (DMPFC), right medial 
frontal cortex (MeFC), and bilateral parietal areas (Table 4, Fig. 1), 
whereas the other paralimbic regions including left insula, and 
right parahippocampal gyrus were hyperactive in patients with 
OCD after pharmacotherapy compared to the controls (Table 4).
  Fig. 2B shows the beta values for the switching condition com-
pared to the repeat condition in controls and patients at pre- and 
post-treatment. The 16-week treatment significantly increased 
activity in the ventral frontal, striatal, and limbic/paralimbic re-
gions including the caudate, VLPFC, rostral ACC, thalamus, in-
sula, and hippocampus. In contrast, no significant difference was 
observed in dorsal frontoparietal regions including the DLPFC 
and parietal area following pharmacotherapy. Hyperactivity ob-
served in the insula of the OCD group following treatment was 
significant compared with the control subjects, and the increase 
in activity in the OFC and dorsal ACC were not significant.
Correlation analysis
A significant correlation was observed between the longitudi-
Table 3. Brain regions displaying significant differences in activation during task-switching between patients with OCD at baseline and controls
Area of activation L/R BA
MNI coordinates
T-value
x y z
Controls > OCD at Baseline
Dorsolateral prefrontal cortex R
L
8
8
38
-26
18
26
50
52
5.26 
5.13 
Dorsomedial prefrontal cortex R 8 18 34 56 4.16*
Medial frontal cortex R 6 18 8 54 3.88*
Premotor area L 6 -42 -10 52 4.64 
Ventrolateral prefrontal cortex R
L
 
10
44
-36
32
52
4
2
3.88*
3.72*
Orbitofrontal cortex R 11 34 36 -14 4.98 
Rostral anterior cingulate cortex R 24 6 30 12 4.42 
Dorsal anterior cingulate cortex L 32 -2 32 26 3.98 
Posterior cingulate cortex R 23 8 -22 36 4.62 
Caudate R
L
28
-22
0
-8
18
18
4.04 
4.82 
Thalamus L -6 0 4 3.53 
Hippocampus R
L
 
28
22
-24
-12
-12
-10
-24
4.01*
4.23 
Insula R 13 40 -18 4 4.25 
Parietal lobe R
L
7
3
14
-24
-60
-34
48
48
4.10 
4.69 
Middle temporal gyrus R 39 56 -66 24 4.13 
Superior temporal gyrus L 22 -66 -38 4 3.93 
Occipital lobe L -22 -60 16 4.48
All activations at P < 0.005 uncorrected at the voxel level with P < 0.05 at the cluster level or at *P < 0.005 uncorrected with a cluster of more than 30 for regions of a priori 
interest based on our previous study (3). L, Left; R, Right; BA, Brodmann’s area; MNI, Montreal Neurological Institute.
Fig. 1. Decreased activation in OCD patients before and after treatment compared to the controls (for illustrative purpose, P < 0.005 uncorrected, cluster level > 30). Activation 
in ventral frontal regions in OCD was normalized after treatment. However, dysfunctional activation in dorsal frontal regions persisted regardless of treatment. 
Controls > OCD at baseline Controls > OCD at follow-up Common regionHan JY, et al.  •  Brain Activation after Therapy in OCD
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nal change (activity at post-treatment minus activity at pre-treat-
ment) in the left thalamus and right insula and the percent im-
provement on the Y-BOCS scores following the 16-week phar-
macotherapy. The correlation coefficient between the change 
in activity in the left thalamus and percent of Y-BOCS improve-
ment was -0.82 (P = 0.004), and that between the change from 
baseline to endpoint between the right insula activity and BAI 
was -0.72 (P = 0.02). After correcting for multiple testing, only the 
correlation between the change in thalamus activity and per-
cent Y-BOCS improvement was significant (< 0.006; corrected P 
= 0.05/9) (Fig. 3). Improvement in behavior and longitudinal 
changes in brain activity were not correlated. 
Fixed effects results in patients before and after treatment 
separately
During task-switch minus task-repeat contrast, both patients at 
baseline and follow-up observed activation in the DLPFC and 
parietal cortex, which is consistent with the results of previous 
studies in healthy volunteers (Fig. 4). While patients at baseline 
showed activation in the OFC, patients at follow-up did not ex-
hibit this activation. In contrast, patients at follow-up showed 
activation in the thalamus, ACC, and caudate.
A
DLPFC Parietal
Insula R L rACC Hipp OFC Thalamus Caudate VLPFC
B
P
a
r
a
m
e
t
e
r
 
e
s
t
i
m
a
t
e
0.10
0.06
0.02
-0.02
-0.06
-0.10
DLPFC rACC Caudate Thalamus Parietal OFC VLPFC Insula Hipp
* * *
* * *
Controls (n = 20) Patients at baseline (n = 10) Patients at follow-up (n = 10)
Fig. 2. The different activations between OCD patients at baseline and controls and between pre- and post-treatment in patients. (A) Dysfunctional activation pattern was 
sustained in the dorsal frontoparietal regions, indicated by the blue line circle, while the ventral frontal, striatal and limbic/paralimbic regions, indicated by the red line circle, 
were partially normalized after treatment. (B) Mean percent signal change for task-switch minus task-repeat of the controls, pre-treatment and post-treatment OCD patients in 
the ROIs. The significant differences in regional activity between pre- and post-treatment in OCD patients are presented in *P < 0.05, using LSD post hoc test. DLPFC, dorsolateral 
prefrontal cortex; VLPFC, ventrolateral prefrontal cortex; rACC, rostral anterior cingulate cortex; OFC, orbitofrontal cortex; Hipp, Hippocampus.
Fig. 3. The correlation of percent (%) Y-BOCS improvement and longitudinal change 
in left thalamus activation. The correlation coefficient was -0.82 (< 0.006; corrected 
P value = 0.05/9).
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Table 4. Brain regions displaying significant differences in patients with OCD at follow-up compared to patients with OCD at baseline and controls
Area of activation L/R BA
MNI coordinates
T-value
x y z
OCD at Follow-up > OCD at Baseline           
   Rostral anterior cingulate cortex
   Poterior cingulate cortex
   Thalamus
   Hippocampus
   Insula
   Parietal lobe
   Occipital cortex
R
R
L
L
R
R
R
24
23
28
13
5
30
8
8
-6
-20
40
12
18
38
-20
-4
-10
-20
-46
-60
6
34
4
-24
4
66
2
3.97*
4.49 
3.74*
4.04 
4.11 
4.56 
4.83 
OCD at Follow-up > Controls            
   Thalamus
   Insula
   Parahippocampal gyrus
   Fusiform gyrus
   Cerebellum
R
L
R
L
R
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Patients at baseline Patients at follow-up
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Fig. 4. Activation maps showing the results of fixed effects analyses in patients before 
and after treatment separately. Although fixed effects results cannot be generalized 
beyond the samples studies, these results are presented to emphasize the similarities 
and the differences in task-switching-related brain regions in patients with OCD before 
and after treatment. Both patients before and after treatment showed the similar 
activation patterns in the DLPFC and parietal cortex, while different activation patterns 
in the OFC, ACC, and caudate were observed. (A) Surface rendering of fixed effects 
results. (B) Multislice coronal view of fixed effects results. 
DISCUSSION 
The present study used the task-switching paradigm to examine 
the effect of a 16-week pharmacotherapy on the functional ac-
tivation of brain areas mediating cognitive flexibility in patients 
with OCD. We found that the ventral frontal-striatal activation 
was partially normalized with improved clinical symptoms, while 
a dysfunctional activation pattern was sustained in the dorsal 
frontoparietal regions. In addition, treatment decreased the er-
ror rate and RT for both task-switch and task-repeat conditions 
and significantly improved switching cost in OCD patients. The 
decreased switching cost was regarded as the result of improved 
behavioral flexibility. As the switching cost is determined by 
both task-switch and task-repeat RTs (22), a common learning 
effect can be excluded from the results. 
  Several previous studies have suggested that an imbalance 
between direct (excitatory) and indirect (inhibitory) pathways 
in the frontal-striatal circuits was related to the dysfunctional 
neuronal responses and the pathophysiology of OCD (6, 7, 9). 
The imbalance in these pathways is thought to result in hyper-
activity in the ventral frontal-striatal network and reduced ac-
tivity in the dorsal frontal-striatal network. A recent meta-anal-
ysis of voxel-based morphometry studies on OCD showed in-
creased regional gray matter volumes in striatum and decreased 
volumes in dorsal MeFC (23). The report suggested that gray 
matter volumes in striatum were related to the symptom sever-Han JY, et al.  •  Brain Activation after Therapy in OCD
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ity and functional alterations in ventral frontal regions such as 
OFC might be compensatory responses. Thus, although deficits 
in ventral frontal-striatal regions may be state-dependent, pri-
mary alterations in dorsal frontal-striatal regions may not im-
prove after a short period of treatment. Incoherent treatment 
response patterns between ventral and dorsal frontal-striatal 
circuits after pharmacotherapy were anticipated in the present 
study. As expected, in this study we showed discordance in func-
tional improvement between the ventral frontal-striatal and dor-
sal frontoparietal regions following treatment, that is improved 
functional activation in ventral frontal-striatal regions in addi-
tion to sustained dysfunctional activation in dorsal frontoparie-
tal regions. Fixed effects results also showed differential activa-
tion pattern in the frontoparietal regions, which is the similari-
ties in the DLPFC and parietal cortex and the differences in the 
OFC, thalamus, ACC, and caudate between patients at baseline 
and follow-up. 
  Clinical improvement in the OCD group was associated with 
an overall change in brain activity in the ventral frontal and stri-
atal regions during task switching. This finding was consistent 
with previous follow-up studies using PET (13-16). Previous neu-
roimaging studies reported that the improvement of symptoms 
in patients with OCD was accompanied by metabolic changes 
in the VLPFC, OFC, ACC, caudate nucleus, and thalamus (13-
16, 24). Furthermore, reversible neuronal responses were ob-
served in the white matter of the thalamus in patients with OCD 
following 12 weeks of citalopram treatment (25). Moreover, a 
previous longitudinal fMRI study found that improvement in 
symptoms was associated with decreased activation in the OFC, 
ACC, thalamus, and insula during a symptom provocation task 
(12). This finding is similar to the changes we observed in ven-
tral frontal and limbic/paralimbic activation. However, the lon-
gitudinal change in OFC activation was not significant in our 
random effects analysis, possibly because the OFC abnormali-
ties associated with maintaining the previous task-set were not 
sufficiently improved (3). This result was also demonstrated by 
Nabeyama et al. (11) in a follow-up study using the Stroop task.
  Pharmacotherapy increased activity in the thalamus and lim-
bic areas and produced a tendency toward hyperactivity in the 
left insula and right parahippocampal gyrus in patients with OCD. 
A possible explanation for this is that a reduction in anxiety, re-
sulting from improved symptoms, produced an increase in lim-
bic system activation. This suggests that the hypoactive ventral 
frontal and limbic regions can be modified in OCD by therapeu-
tic interventions as a state marker (10, 26). Additionally, the com-
pensatory responsiveness in the limbic/paralimbic regions (9) 
may be associated with excessive activity in the automatic sub-
processes of the ventral circuit (7, 27). 
  In the present study, post-treatment thalamic activity was in-
creased, and the thalamic activity change was negatively corre-
lated with the OC symptoms improvement; thus, treatment in-
creased activity in the thalamus, but less improved patients 
showed more increased activity in thalamus. In contrast, Zitterl 
et al. (28) reported a negative association between OCD symp-
tom severity and thalamic/hypothalamic serotonin transporter 
availability in both the baseline and post-treatment conditions. 
Given the hyperactive pattern in the limbic and paralimbic re-
gions, the inverse relationship between changes of thalamic ac-
tivity and OC symptom severity may be a compensatory mech-
anism for unfulfilled improvement of OC symptoms or a over-
loaded result in the frontal-striatal circuit (7). As hypothesized by 
Saxena and Rauch (9), excess activity in the direct (as opposed 
to indirect) frontal-striatal pathway may lead to enhanced acti-
vation of regions including the medial-dorsal thalamus. 
  The DLPFC and parietal region are known to be important 
for cognitive flexibility (29). Fixed effects results showed activa-
tion of these regions in both patients at baseline and follow-up. 
Considering above results, it is not clear whether treatment al-
tered the dorsal frontal and parietal dysfunction. However, a com-
parison between patients with OCD at post-treatment and con-
trol subjects revealed a sustained deactivation in the bilateral 
DLPFC and bilateral parietal cortex in the OCD group. Decreased 
activation in the frontal cortex (BA 9, 10) in response to the Stroop 
task (12) and unchanged activity in the frontal cortex reported 
in a follow-up fMRI study in children and adolescents with OCD 
(10) agree with the sustained decrease in DLPFC activation ob-
served in the present study. In contrast, studies using a variety 
of approaches to examine the effect of treatment on activation 
of the parietal region in OCD have reported inconsistent results 
as exhibiting a non-significant change in the N-acetylaspartate 
level in the parietal region (30) and increased activation during 
the Stroop task (12).
  Our study has some limitations. First, the sample size was rel-
atively small and thus our results may be difficult to generalize 
because of the limited statistical power. However, the repeated-
measures longitudinal design in unmedicated patients is valu-
able for distinguishing pathophysiological traits from states in 
patients. Second, depression and anxiety levels were significant-
ly higher in OCD patients than in healthy controls, which could 
have potential confounding effects. In this study, differences 
between group and detected changes in brain activity could be 
due to comorbid symptoms such as depression or anxiety. How-
ever, no patients were diagnosed with major depressive disorder 
or other specific anxiety disorder according to the SCID I. In ad-
dition, we attempted to address the effects of depression or anx-
iety levels based on a correlation analysis with activation in each 
functional ROI and found no significant correlation, except a 
negative correlation between changes in insular activity and 
BAI. We also examined the group effect for each ROI using anal-
ysis of covariance with depression and anxiety level as covari-
ates and there were no differences between the results of these 
added analysis and those of ANOVA. Finally, the task-switching Han JY, et al.  •  Brain Activation after Therapy in OCD
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paradigm primarily recruited the specific area of brain, prefron-
tal cortex and posterior parietal cortex rather than subcortical 
region; thus, our study is preliminary results. Further connec-
tivity analyses are needed to investigate clearly the response of 
the striatal areas to the between dorsal and ventral circuits.
  In summary, our preliminary results indicate that the flexibil-
ity deficit in OCD as assessed using the switching task is associ-
ated with dysfunctional activity patterns in the frontal-striatal 
and parietal regions. We demonstrated that selectively increased 
activity in the ventral frontal, striatal, and limbic regions produc-
es an incomplete but considerable improvement in clinical symp-
toms and behavior. However, as we hypothesized, dysfunction-
al activity in dorsal frontoparietal regions in patients with OCD 
was sustained. Our results suggest that altered brain activation 
in ventral frontal-striatal regions in OCD patients was associat-
ed with their cognitive flexibility and changes in these regions 
may underlie the pathophysiology of OCD.
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The patient with obsessive compulsive disorder (OCD) showed abnormalities in brain regions associated with cognitive flexibility. 
Cognitive flexibility is the ability to switch behavioral response according to the context of the situation. However, little is known 
about activity changes in the brain regions associated with cognitive flexibility after treatment. Therefore, we scanned functional 
magnetic resonance imaging during cognitive flexibility task for each patient before and after treatment. We have found that the 
neural responses in the ventral brain regions of OCD patients were normalized with medications. However, dorsal brain regions 
showed persistent abnormal activation pattern. We also found that the thalamic activity change was negatively correlated with 
the improvement of OCD symptoms.